Decolonizing the Pandemic Treaty Through Vaccine Equity
Putting vaccine equity at the center of a pandemic treaty will already be a huge step towards global health’s decolonization.
Pharmaceuticals
-
Read more: Decolonizing the Pandemic Treaty Through Vaccine Equity -
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of September 2021.
-
Read more: The Pandemic Treaty and Intellectual Property Sharing: Making Vaccine Knowledge a Public Good The Pandemic Treaty and Intellectual Property Sharing: Making Vaccine Knowledge a Public Good
The pandemic has laid bare the lack of regulation for the sharing of intellectual property needed for an effective and equitable response.
-
Read more: Promoting Vaccine Equity Promoting Vaccine Equity
The COVID-19 pandemic has brought into sharp relief longstanding equity problems surrounding the allocation of newly developed vaccines.
-
Read more: Should Vaccinating Children Off-Label Against COVID-19 Be Universally Prohibited? Should Vaccinating Children Off-Label Against COVID-19 Be Universally Prohibited?
We think that off-label pediatric administration of approved COVID-19 vaccines should be left to individual risk-benefit judgments.
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of August 2021.
-
Read more: Fatty Acids, Skinny Labels: Fish Oil Patent Battle Back in Court Fatty Acids, Skinny Labels: Fish Oil Patent Battle Back in Court
An ongoing patent battle over omega-3 fatty acids may have broad implications for the marketing of generic drugs.
-
Read more: The Age of Orphans The Age of Orphans
Orphan medicines are available for a larger number of diseases and patients than ever before.
-
Read more: Tackling Salami Slicing and Indication Stacking in Orphan Drug Innovation Incentives Tackling Salami Slicing and Indication Stacking in Orphan Drug Innovation Incentives
Are the incentive mechanisms for orphan drug development working as they should?
-
Read more: Mortal Sins of Orphan Drug Development: How to Save the Lost Souls Mortal Sins of Orphan Drug Development: How to Save the Lost Souls
Before we can consider ways to address excessive pricing for orphan drugs, we must first diagnose the underlying problem.
